Schering-Plough (SGP) Possible Merger With Brystol-Myers (BMY)
Schering-Plough Corp. (SGP) is seriously considering approaching Bristol-Myers Squibb Co. (BMY) about a possible merger, a move that would combine two of the biggest names in the pharmaceutical industry, the Star-Ledger of Newark, N.J., reports in Friday's editions. Such a deal would give Schering-Plough a coveted drug-discovery pipeline and a formidable stable of cancer treatments and antiviral therapies for HIV/AIDS and hepatitis C. For Bristol-Myers, which this week fired its chief executive amid a criminal probe, Schering-Plough would bring much-needed revenue from the hot-selling cholesterol fighter Vytorin and CEO Fred Hassan, an experienced turnaround artist who is among the most respected leaders in the industry, according to the Star-Ledger. If such a merger closes, expect the price to rise. These two stocks could be good speculative plays based on this pending deal, not to mention that SGP is a good stock to buy at this point.
posted by Stock Administrator @ 1:35 PM
Schering-Plough (SGP) Possible Merger With Brystol-Myers (BMY)
Schering-Plough Corp. (SGP) is seriously considering approaching Bristol-Myers Squibb Co. (BMY) about a possible merger, a move that would combine two of the biggest names in the pharmaceutical industry, the Star-Ledger of Newark, N.J., reports in Friday's editions. Such a deal would give Schering-Plough a coveted drug-discovery pipeline and a formidable stable of cancer treatments and antiviral therapies for HIV/AIDS and hepatitis C. For Bristol-Myers, which this week fired its chief executive amid a criminal probe, Schering-Plough would bring much-needed revenue from the hot-selling cholesterol fighter Vytorin and CEO Fred Hassan, an experienced turnaround artist who is among the most respected leaders in the industry, according to the Star-Ledger. If such a merger closes, expect the price to rise. These two stocks could be good speculative plays based on this pending deal, not to mention that SGP is a good stock to buy at this point.
posted by Stock Administrator @ 1:35 PM
0 Comments:
Post a Comment
<< Home